+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Oncology Drugs Market Research Reports

From
From
From
From
From
From
From
From
From
From
From
From
From
From
From
From
From
Mitotane - Global Strategic Business Report - Product Thumbnail Image

Mitotane - Global Strategic Business Report

  • Report
  • July 2025
  • 279 Pages
  • Global
From
Hepatoblastoma Treatment - Global Strategic Business Report - Product Thumbnail Image

Hepatoblastoma Treatment - Global Strategic Business Report

  • Report
  • July 2025
  • 391 Pages
  • Global
From
Multiple Myeloma Drugs - Global Strategic Business Report - Product Thumbnail Image

Multiple Myeloma Drugs - Global Strategic Business Report

  • Report
  • July 2025
  • 274 Pages
  • Global
From
Loading Indicator

The Oncology Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cancer. These drugs are used to treat a variety of cancers, including breast, lung, and prostate cancer. Oncology drugs are typically administered intravenously or orally, and can be used in combination with other treatments such as radiation and chemotherapy. The Oncology Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Bristol-Myers Squibb, Merck & Co., Pfizer, Novartis, and Roche. These companies are constantly researching and developing new drugs to treat cancer, as well as improving existing treatments. Additionally, many smaller companies are also involved in the Oncology Drugs market, providing innovative treatments and therapies. Show Less Read more